stock pickSCDemail_stock_pick
Unlock SCD Insights: NHLBI's New Walk-PHaSST Data!
# Unlock SCD Insights: NHLBI's New Walk-PHaSST Data!
Read moreFeatured By
Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# Unlock SCD Insights: NHLBI's New Walk-PHaSST Data!
Read more# APLS: Breakthrough in Rare Disease Treatment Unveiled! ## Introduction Apellis Pharmaceuticals (NASDAQ: **APLS**) is a biotechnology company focused on therapies targeting the…
Read more# ORCL Investors: Class Action Alert & Key Deadline! **Oracle Corp. (NYSE: ORCL)** is facing intensified scrutiny amid a new securities class action lawsuit and an upcoming…
Read more# CNS: Major Trial Launch Could Shift Market Dynamics! **Company Overview:** Cohen & Steers, Inc. *(NYSE: CNS)* is a global investment manager specializing in real assets and…
Read more# MYRG: Don’t Miss MYR Group at Jefferies Conference! ## Company Overview & Recent Performance MYR Group Inc. (NASDAQ: MYRG) is a **leading specialty electrical contractor**…
Read more# EDSA: New Phase 3 Study Results Could Drive Gains!
Read more# MREO: Pomerantz Law Firm’s Class Action Alert!
Read more# **ABBV: Unlocking Potential Amidst Market Shifts!** **AbbVie (NYSE: ABBV)** is a global biopharmaceutical leader undergoing a major transition as its blockbuster drug **Humira**…
Read more# CTEV: Claritev Shareholders Can Recover Losses Now! ## Introduction **Claritev Corporation (NYSE: CTEV)** is a healthcare technology and data insights company focused on making…
Read more# RARE: Class Action Alert — Know Your Rights Now! ## Class Action Overview and Allegations Ultragenyx Pharmaceutical Inc.
Read more# WTW’s New Leader in Singapore: What You Need to Know! ## New Leadership in Singapore and Strategic Focus Willis Towers Watson (branded as **WTW**, NASDAQ: WTW) recently…
Read more# JUNS: Major Update at Mar-a-Lago Investor Dinner! **Jupiter Neurosciences, Inc. (NASDAQ: JUNS)** is a clinical-stage pharmaceutical company focused on neuroinflammation and CNS…
Read more# CLDX: Q4 2025 Results & Corporate Update Unveiled! ## Introduction Celldex Therapeutics (NASDAQ: **CLDX**), a clinical-stage biopharmaceutical company, has unveiled its…
Read more# GERN: Don't Miss Key Insights from Q4 Earnings Call!
Read more# LLY's Phase 3 VIVID-2 Study: A Game Changer in Health!
Read more# MREO Class Action Alert: Deadline Approaches March 6, 2026!
Read more# TNXP: Don’t Miss Tonix’s Key Investor Conferences in March! ## Company Overview and March 2026 Investor Events Tonix Pharmaceuticals Holding Corp.
Read more# IFS: Fitch Upgrades SiriusPoint Subsidiaries to ‘A’!
Read moreORCL Soars to $147.89: Analyst Upgrade Sparks AI Buzz! Surging Stock on AI Optimism and Upgrade Oracle Corporation’s stock (NYSE: ORCL) has been on a tear, recently surging to…
Read more# E: Don’t Miss ENI's ‘Beast Games’ Season 2 Finale Insights! ## Introduction Eni S.p.A. (NYSE: **E**), Italy’s multinational oil & gas **“beast”**, has delivered a strong…
Read more